Pharma Latch Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Pharma Latch General Information

Description

Developer of a tissue anchor system designed to unlock the potential of drugs and vaccines while enhancing the patient experience. The company uses micro-needle technology and focuses on opposing arrays of angled microneedles that painlessly penetrate the outer layers of the skin while ensuring consistent needle penetration, and has developed intradermal injection devices based on a core platform technology, enabling healthcare professionals with better alternatives to stitch a wound.

Contact Information

Formerly Known As
Latch Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nova UCD
  • Belfield Innovation Park University College Dublin
  • Dublin D04 V2P1
  • Ireland
+353 (01)
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Nova UCD
  • Belfield Innovation Park University College Dublin
  • Dublin D04 V2P1
  • Ireland
+353 (01)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharma Latch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 21-Aug-2026 Completed Generating Revenue
5. Later Stage VC 11-Aug-2022 Completed Generating Revenue
4. Accelerator/Incubator 02-Jun-2020 Completed Generating Revenue
3. Early Stage VC 12-Jul-2019 Completed Generating Revenue
2. Grant 19-Oct-2018 $8.12K Completed Generating Revenue
1. Accelerator/Incubator 18-Nov-2016 Completed Generating Revenue
To view Pharma Latch’s complete valuation and funding history, request access »

Pharma Latch Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
CRCPS 350,000 $0.001017 $1.02 $1.02 1x $1.02 17.12%
To view Pharma Latch’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pharma Latch Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a tissue anchor system designed to unlock the potential of drugs and vaccines while enhancing the patient e
Medical Supplies
Dublin, Ireland
9 As of 2023

Grandview, MO
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharma Latch Competitors (1)

One of Pharma Latch’s competitors is Central Medical Supplies, a Corporation company based in Grandview, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Central Medical Supplies Corporation Grandview, MO
You’re viewing 1 of 1 competitors. Get the full list »

Pharma Latch Patents

Pharma Latch Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4821524-A1 A syringe coupling and microneedle based delivery device for use with same Pending 11-Apr-2025
WO-2026215337-A1 A syringe coupling and microneedle based delivery device for use with same Pending 11-Apr-2025
EP-4529943-A1 Needle assembly with integrated guard Inactive 29-Sep-2023
EP-4784216-A1 Needle assembly with integrated guard Pending 29-Sep-2023
WO-2025068118-A1 Needle assembly with integrated guard Inactive 29-Sep-2023 A61M37/0015
To view Pharma Latch’s complete patent history, request access »

Pharma Latch Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharma Latch Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
West Pharmaceutical Services Corporation Minority
EIT Health Accelerator/Incubator
Atlantic Bridge Capital Growth/Expansion Minority
Enterprise Ireland Growth/Expansion Minority
To view Pharma Latch’s complete investors history, request access »

Pharma Latch FAQs

  • When was Pharma Latch founded?

    Pharma Latch was founded in 2016.

  • Where is Pharma Latch headquartered?

    Pharma Latch is headquartered in Dublin, Ireland.

  • What is the size of Pharma Latch?

    Pharma Latch has 9 total employees.

  • What industry is Pharma Latch in?

    Pharma Latch’s primary industry is Medical Supplies.

  • Is Pharma Latch a private or public company?

    Pharma Latch is a Private company.

  • What is Pharma Latch’s current revenue?

    The current revenue for Pharma Latch is .

  • How much funding has Pharma Latch raised over time?

    Pharma Latch has raised $4.23M.

  • Who are Pharma Latch’s investors?

    West Pharmaceutical Services, EIT Health, Atlantic Bridge Capital, and Enterprise Ireland have invested in Pharma Latch.

  • Who are Pharma Latch’s competitors?

    Central Medical Supplies is a competitor of Pharma Latch.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process